Boston Scientific Corporation

NYSE:BSX

Market Cap

USD 153.09 B

Share Price

USD 103.48

Avg Daily Volume

7,749,481

Change (1 day)

-0.81%

Change (1 year)

32.63%

Change (YTD)

15.85%

Boston Scientific Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 15.96%

Boston Scientific Corporation EBIT Margin is 15.96% for the Trailing 12 Months (TTM) ending March 31, 2025, a -3.10% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Boston Scientific Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 16.47%, a 27.19% change year over year.
  • Boston Scientific Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 12.95%, a 7.49% change year over year.
  • Boston Scientific Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 12.05%, a 104.58% change year over year.
  • Boston Scientific Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 5.89%, a -10.30% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin